Figs Inc

wearfigs.com

The filing excerpts provided do not contain sufficient business description, financial, or operational data to produce a SEC-grounded company summary for Figs Inc (NYSE: FIGS). The excerpts consist solely of boilerplate SEC cover page language with no readable content about business activities, revenue streams, products, customers, competitors, or financial results. A canonical description cannot be written without fabricating facts not supported by the provided source material.

Peers: ATRION CORP Avanos Medical Inc Embecta Corp ICU Medical Inc MERIDIAN BIOSCIENCE INC Merit Medical Systems Inc Neogen Corp Silk Road Medical Inc STAAR Surgical Co

Source: SEC 10-K, filed 2026-02-26

Dive deeper

Financial Snapshot

Revenue

TTM

$710.1M

Gross Margin

TTM

68.95%

Net Income

TTM

$61.92M

Current Assets

2026 Q2

$452.9M

Current Liabilities

2026 Q2

$91.38M

Current Ratio

2026 Q2

495.63%

Total Assets

2026 Q2

$582.7M

Total Liabilities

2026 Q2

$140.3M

Book Value

2026 Q2

$442.4M

Cash

2026 Q2

$108.5M

P/E

TTM

39.39

Free Cash Flow

TTM

$52.97M

Stock Price

Market Cap: $2.4389 Billion